Ofatumumab is chemotherapy and targeted therapy drug which is available in two brand names Arzerra and Kesimpta. Arzerra is approved for Chronic lymphocytic leukemia whereas Kesimpta is approved for Relapsing multiple sclerosis.
Category:
Medicine
-
-
Obinutuzumab is a targeted therapy drug used to treat Chronic Lymphocytic Leukemia and Follicular lymphoma.
-
“Nivolumab is a targeted therapy drug used to treat Melanoma, Metastatic Non-small cell lung cancer, Metastatic small cell lung cancer, Advanced kidney cancer, Liver cancer, Hodgkin’s lymphoma, Metastatic squamous cell carcinoma of the head and neck, Advanced or metastatic urothelial carcinoma, and Colorectal cancer.”
-
-
-
Imatinib mesylate is a targeted therapy drug used to treat Chronic myeloid leukemia, Acute lymphoblastic leukemia, Gastrointestinal stromal tumours, Hypereosinophilic syndrome, Dermatofibrosarcoma protuberans, Systemic mastocytosis, Myelodysplastic or myeloproliferative diseases.
-
-
“Ibritumomab tiuxetan is a targeted therapy drug used to treat Non-Hodgkin’s lymphoma and Follicular B-cell non-Hodgkin’s lymphoma.”
-
-
Everolimus is a targeted therapy drug used to treat Breast cancer, Kidney cancer, Pancreatic cancer, stomach cancer, Lung cancer, Subependymal giant cell astrocytoma (a type of brain tumour), and Prevents transplant rejection in patients who have received kidney transplantation.
